Eicosapentaenoic acid
Pro Research Analysisby 
Searched over 200M research papers for "eicosapentaenoic acid"
Eicosapentaenoic Acid: Therapeutic Benefits and Mechanisms
Eicosapentaenoic Acid in Cancer Cachexia Treatment
Cancer Cachexia and EPA
Cancer cachexia is a severe weight loss syndrome seen in advanced cancer patients, leading to reduced quality of life and shorter survival times. Eicosapentaenoic acid (EPA), a long-chain polyunsaturated fatty acid found in fish, has been studied for its potential to alleviate symptoms of cachexia. However, current research indicates that there is insufficient data to conclusively determine whether oral EPA is more effective than placebo in improving symptoms associated with cancer cachexia .
EPA and Liver Health
Steatohepatitis and Hepatocellular Carcinoma
EPA has shown promise in ameliorating steatohepatitis and reducing the development of hepatocellular carcinoma (HCC) in hepatocyte-specific Pten-deficient mice. The beneficial effects are attributed to decreased expression of AMPKalpha1-mediated SREBP-1c, increased PPARalpha expression, and reduced reactive oxygen species (ROS) formation .
Cholesterol Esterification
In cultured rat hepatocytes, EPA significantly reduces cholesterol esterification and secretion by inhibiting the activity of acyl-CoA:cholesterol acyltransferase. This reduction in cholesterol esterification leads to decreased secretion of very low-density lipoprotein cholesterol ester, highlighting EPA's potential in managing cholesterol levels Rustan1988Rustan1988.
Cardiovascular Benefits of EPA
Triglyceride Levels
EPA, particularly in the form of AMR101, has been shown to significantly reduce triglyceride levels in patients with very high triglyceride levels without increasing low-density lipoprotein (LDL) cholesterol levels. This effect is crucial as other triglyceride-lowering therapies often increase LDL cholesterol .
Coronary Events
Long-term use of EPA has been associated with a 19% relative reduction in major coronary events in hypercholesterolemic patients. This reduction includes non-fatal coronary events such as unstable angina and myocardial infarction, making EPA a promising treatment for coronary artery disease prevention .
Carotid Intima-Media Thickness
In patients with type 2 diabetes, EPA has been shown to reduce the progression of carotid intima-media thickness (IMT) and improve brachial-ankle pulse wave velocity (baPWV), indicating its potential in reducing diabetic macroangiopathy .
Neurological Protection
Cerebral Ischemia
EPA has demonstrated protective effects against cerebral ischemia in gerbils by preventing post-ischemic cerebral edema and hypoperfusion. This protection is achieved without altering the levels of brain diene prostaglandins and thromboxane, suggesting a unique mechanism of action .
EPA in Colorectal Adenoma Prevention
Colorectal Adenomas
Despite its potential in other areas, EPA, alone or in combination with aspirin, did not significantly reduce the proportion of patients with at least one colorectal adenoma in a multicenter, randomized, double-blind, placebo-controlled trial. This finding suggests that further research is needed to explore the optimal use of EPA in colorectal adenoma prevention .
Conclusion
Eicosapentaenoic acid (EPA) exhibits a range of therapeutic benefits, particularly in cardiovascular health, liver function, and neurological protection. While its efficacy in cancer cachexia and colorectal adenoma prevention remains inconclusive, EPA's role in reducing triglyceride levels, preventing coronary events, and ameliorating liver conditions underscores its potential as a valuable therapeutic agent. Further research is warranted to fully elucidate the optimal applications and mechanisms of EPA in various health conditions.
Sources and full results
Most relevant research papers on this topic